ArticleAdvances in radiation oncology

Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapy.

Nicholas Courtier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.